EuroAPI lists on Euronext Paris
Karl Rotthier, CEO of EuroAPI, opens the trading day in Paris.
EuroAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc.
EuroAPI has 6 production sites located in France (2), the United Kingdom, Germany, Italy and Hungary.